Hydrocephalus Market Research Report Information by Type (Congenital Hydrocephalus, Acquired Hydrocephalus, Normal-Pressure Hydrocephalus, Ex-Vacuo Hydrocephalus), Diagnostic (CT scan – head, MRI, Head Ultrasound), Treatment (Surgery – Shunt Insertion, Ventriculostomy, Medication), End User (Hospitals & Clinics, Diagnostic Centres, Academic Institutions and Research Organizations) and Region - Forecast till 2032

Hydrocephalus Market Overview

The Hydrocephalus Market Size was valued at USD 0.54 Billion in 2023. The Global Hydrocephalus industry is projected to grow from USD 0.58 Billion in 2024 to USD 0.92 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.32% during the forecast period (2024 - 2032). The whole market of Hydrocephalus is expected to gain in the forecast period. Although the growth rate is not a double-digit one, the Market will not see stagnancy. The Market is a significant one because of the importance Hydrocephalus condition gets in today’s healthcare. However, the market is looking at different conditions. The present market scenario and future projections of the Market are discussed in this Market Outlook.

Hydrocephalus is a neural ailment that arises when CSF accumulates within the cranial cavities of a person. It is a very serious ailment that should not be neglected in any case. The accumulation of CSF leads to enlargement in vein size. This, in turn, causes the brain of the patient to swell unnaturally. This accumulation of CSF leads to damage to brain tissues. The brain and spinal tissues suffer considerable damage if Hydrocephalus is not treated properly. Hydrocephalus is a rare condition, but it arises in infants and adults over the age of 60. During these ages, the brain and neural systems are invulnerable systems.

Hydrocephalus at any age can be very dangerous for the patient. Its consequences range from sleepiness, vomiting to seizures and imbalance. While it can happen in people due to many reasons, the cause of obstruction in normal CSF flow is very common. If the person has suffered some internal bleeding or has a tumor in the brain, the chances of Hydrocephalus are high. Another cause is the overproduction of CSF which topples the balance of CSF flow in the nervous system. This can also lead to Hydrocephalus. However, overproduction is very rare.

No matter how rare the condition is, it is painful and dangerous. Thus, it needs immediate treatment. Therefore, the Hydrocephalus Industry plays a huge role in modern healthcare.

Cumulative Growth Analysis

The growth rate of the Market may not be as high as a double-digit CAGR, but it is enough to keep the market moving towards better Market trends. As the population becomes more self-aware about Hydrocephalus and its treatment, the Hydrocephalus Industry Trends will turn positive.

COVID 19 Analysis

The COVID 19 pandemic has affected every industrial vertical, and the Hydrocephalus Industry is no stranger to the impact of COVID 19. The Hydrocephalus Market is facing newer challenges and restraints under the impact of the COVID 19 pandemic. The COVID 19 pandemic has created supply chain challenges where there were none before. The Hydrocephalus Industry is struggling to supply hydrocephalic treatment approaches to the global patient population.

The unavailability of skilled human resources in the neurological sector is also affecting the Market in the post-pandemic phase. Similarly, the shutdown of neurological wards and clinics is also a negative Hydrocephalus Market Trend. The Market, therefore, does not show a high rate of growth in the pandemic and post-pandemic years. The neurological healthcare sector is also running out of resources as most of the resources are directed towards COVID 19 treatment. In such circumstances, the Market does not advance at a healthy rate. The overall impact of the COVID 19 pandemic has been unfavorable for the Hydrocephalus Industry.

CereVasc has been granted investigational device exemption (IDE) approval by the US Food and Drug Administration (FDA) to commence the STRIDE pivotal study of its eShunt system for the treatment of normal pressure hydrocephalus (NPH) in May 2024. The system consists of an endovascularly implantable cerebral spinal fluid shunt (CSF) and associated delivery components, which will mitigate the necessity for general anesthesia, invasive surgery, protracted hospitalization, and post-procedure pain reduction. It is designed to significantly reduce the number of defects associated with ventriculoperitoneal shunt systems, including catheter obstruction, overdrainage, and infection. The eShunt System offers percutaneous transvenous-transdural access to the central nervous system.

Anuncia Medical Inc., a company that specializes in the advancement of innovations for implantable and external cerebrospinal fluid (CSF) management systems and neurocritical care, is pleased to announce the successful U.S. commercial launch of the ReFlow™ Mini Flusher device. This announcement was made in July 2023. Neurosurgeons in the United States and shortly internationally will have a new option to mitigate the effects of hydrocephalus by enhancing access to potentially life-saving therapy for the 30 million patients worldwide who are affected by this neurological disorder. Hydracephalus is a chronic neurological condition that results in the accumulation of excess cerebrospinal fluid (CSF) in the brain. This condition frequently leads to severe symptoms, frequent hospitalizations, and ongoing health concerns, and it may be fatal if left untreated. The second-generation ReFlow Mini Flusher, which was recently introduced, has been approved by the FDA for use in patients with hydrocephalus or comparable conditions. It is intended to provide more comprehensive support to a wider range of hydrocephalus patients, including neonates and older adults, due to its smaller size and profile. The ReFlow Mini Flusher, a patented device that is compatible with any shunt system brand, is specifically engineered to return the patient's cerebrospinal fluid (CSF) to the ventricular catheter, thereby maintaining, restoring, or enhancing the flow of the hydrocephalus shunt. This is accomplished by simply pressing the soft dome of the flusher, which is situated beneath the patient's scalp. Noninvasive flushing with the ReFlow Mini Flusher does not disrupt the regulation of shunt flow and can be conducted by trained clinical personnel in the clinic or by a trained patient/caregiver at any location, as directed by the treating neurosurgeon.

Hydrocephalus Market Trends

The key drivers of the market

The increased incidence of Hydrocephalus in people and infants is a major driver of the Hydrocephalus Industry. According to an academic study in 2019, the incidence of pediatric Hydrocephalus is 88 out of 100,000 births globally. This is an increased incidence of Hydrocephalus in infants. On the other hand, the increase in life-threatening accidents and brain injuries in adults is also driving the growth of the Hydrocephalus Industry. The increased prevalence of the two indicators is a favorable one for the market of Hydrocephalus.

Significant opportunities

Besides the increased prevalence of induced Hydrocephalus, the increase in the incidence of neurological disorders due to lifestyle diseases is also an opportunity for the Hydrocephalus Market Size to increase its product portfolio and application. The incidence of congenital defects in the present generation is also increasing. This produces another window of opportunity for expanding the Hydrocephalus Industry Size. All these factors may seem dreary, but they are instrumental in presenting new opportunities to the Market for Hydrocephalus Industry Growth. Another opportunity for Market Growth is the use of advanced surgical techniques with the help of valves. When people become aware of the possible treatment of Hydrocephalus, it will only drive the growth of the Market further.

Market Restraints

There are some restraints that limit the Hydrocephalus Industry Growth in the long run. These restraints are no different from the usual restraints that exist in the healthcare sector. With advanced treatment procedures, there is always a chance that an implant or treatment approach will lead to a further complication. In the Hydrocephalus Industry, too, the shunts used to relieve pressure from the brain may lead to infections and malfunctions. This causes a decline in the Hydrocephalus Industry share worldwide. Another restraint is the presence of irreversible brain damage due to accidents.

Market Challenges

The market challenges are the ones that can be solved and lead to more growth than limitation. The major challenge, according to market analysis of Hydrocephalus, is the need for research and development of advanced equipment and treatment in the Hydrocephalus Industry. There is a great scope to create an advanced approach to treating Hydrocephalus. However, this needs joint effort from the key players of the Hydrocephalus Industry. When the key players of the Market invest in the advancement of Hydrocephalic treatments, the Market will also progress.

Hydrocephalus Market Segment Overview

The Hydrocephalus Market Analysis points at the different segments of the Market. The Hydrocephalus Industry divides into categories based on type, diagnosis, treatment, and end-user.

By Type- By type, the primary segments of the market are congenital Hydrocephalus and acquired Hydrocephalus.

By diagnostic- By the way, Hydrocephalus is diagnosed, the Market divides into MRI, CT Scan, and head ultrasound.

By surgery- By the surgery that is used to cure the condition, the market disperses into shunt insertion procedure, ventriculostomy, and medication to balance CSF.

By end-user- The major end-user for the Market are hospitals, clinics, and diagnostics centers.

Hydrocephalus Market Regional Analysis

On the basis of the regional analysis for the market of Hydrocephalus, the American region, including North America and South America, will be the major regional markets for Hydrocephalus treatments. The companies that create Hydrocephalus treatment devices dominate the North American region. This then translates into regional dominance for the North American region. There is much interest in the research and development of Hydrocephalus treatment in the region. This is especially true for the USA. However, the European regional market will be the second-largest market for Hydrocephalus treatments. Hydrocephalus in infancy will drive growth in the region.

Competitive landscape 

There are many key players in the Market that dominate the competitive landscape for the market. 

The key players of the Hydrocephalus Market segment are as follows. 

• DePuy Synthes


• Boston Neurosciences


• Medtronic Plc


• Integra Life Sciences Corporation


• Spiegelberg GmbH & Co. KG


• RAUMEDIC Inc


• Sophysa SA


• Terumo Corporation


• Natus Medical Incorporated


• Johnson & Johnson Services Inc

Recent Developments

The key competitors of the Market are investing in research and development of new, advanced Hydrocephalus treatment approaches. The Hydrocephalus Market forecast also predicts that the key players also take up a lot of mergers, collaborations, and acquisitions to achieve a common goal of supporting the Market of Hydrocephalus collectively. The research and development in the area of Hydrocephalus treatments will benefit all the major players of the Market.

Report Overview 

The Hydrocephalus Market Outlook or overview is as follows:

• Market Overview


• COVID 19 Analysis


• Market Dynamics


• Segment Overview


• Regional Analysis


• Competitive Landscape


• Recent Developments

This report focuses on the market of Hydrocephalus and its trends. It highlights the key drivers, significant opportunities for growth and presents market challenges of the Hydrocephalus Industry. Thirdly, it discusses the segmentation of the Hydrocephalus Industry over various benchmarks and segments. Additionally, the Hydrocephalus Industry Outlook sheds more light on the competitive landscape and recent developments of the market. It creates an overall reading of the Hydrocephalus Industry Forecast for the readers.